Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Genzyme
 More »

  • GEN | Biolinks
    ... Biopharmaceuticals GE Healthcare Life Sciences Gene Link Genentech GenTech Scientific Genzyme Georgetown University Georgia Bio Georgia Department of Economic Development Geron ...
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    ... M&A activity rises: The total value of mergers and acquisitions involving U.S. or European biotechs rose last year to $27.4 billion, up 9% over 2011 excluding the Sanofi-Genzyme ...
    4-22-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    (teriflunomide) 2012 sales: $9.1 million (€7 million) 4 Marketer(s): Sanofi (Genzyme) Indication(s): Relapsing forms of multiple sclerosis Date of FDA approval: September ...
    4-4-2013
  • Is This Gene Therapy's Breakout Moment?
    very few, if any, gene-therapy programs being developed by the pharma industry's biggest players. The most advanced such programs have been overseen by Sanofi's Genzyme subsidiary. ...
    4-1-2013
  • Biopharmas Cooling to Licensing Deals as Patent Cliff Fears Ease
    The 2011 figure includes Sanofi's $20.1 billion acquisition of Genzyme. One area where licensing and M&A activity could increase this year, Urquhart said, is orphan drugs, whose ...
    3-28-2013
  • Novel Platform for Immunotherapies Created
    The platform will be based at Genzyme Polyclonals site in Lyon-Gerland area for an ... The platform will remain Sanofi's exclusive property. Sanofi and Genzyme will act as ...
    3-26-2013
  • Top 10 Biopharma Layoffs of 2012
    ... Part of five-year, €2 billion ($2.7 billion) cost-cutting initiative announced in September 2011, following $20.1 billion acquisition of Genzyme earlier that year and loss of ...
    3-15-2013
  • Is This Gene Therapy's Breakout Moment?
    very few, if any, gene-therapy programs being developed by the pharma industry's biggest players. The most advanced such programs have been overseen by Sanofi's Genzyme subsidiary. ...
    3-4-2013
  • Top 10 Biopharma Employers with Certified H-1B Workers
    certified 1 certified-withdrawn; 1 withdrawn; 1 denied #9. Sanofi (and subsidiary Genzyme) 2 24 workers certified 2 certified-withdrawn; 1 denied #8. Biogen Idec 25 workers ...
    2-22-2013
  • Top 10 Biopharma Layoffs of 2012
    ... Part of five-year, €2 billion ($2.7 billion) cost-cutting initiative announced in September 2011, following $20.1 billion acquisition of Genzyme earlier that year and loss of ...
    2-15-2013
  • Profit Slump at Sanofi: Patent Cliff, Restructuring Blamed
    ... which included ongoing changes to manufacturing facilities in Europe, sales force cuts, and consolidation of Genzyme, which Sanofi acquired last year for $20.1 billion. ...
    2-7-2013
  • Progressive MS Therapy Sparks Deal Worth Up to $225M
    ... Sanofi's Genzyme subsidiary said January 30 it expects word from FDA on its application to market its MS drug Lemtrada during the second half of this year. In Europe, the European ...
    2-5-2013
  • Personalized Medicine R&D 3.0: The Return of the Patient
    ... Major firms such as Biogen Idec, Pfizer, and French pharmaceutical giant Sanofi, the parent of Genzyme, are partnering on a number of initiatives with patient groups such as the ...
    2-4-2013
  • People in the News
    Lawton joined OvaScience as COO. Prior to joining OvaScience, she was svp and general manager at Genzyme Biosurgery. Before that, Lawton was svp of global market access at Genzyme. ...
    2-1-2013
  • Pioneering Antisense Drug Gets FDA Approval
    Isis Pharmaceuticals and Sanofi's Genzyme subsidiary said today they are gearing up for ... The FDA approval will result in a $25 million milestone payment to Isis from Genzyme, ...
    1-30-2013

  • Journal Articles

  • Bringing Molecular Biology to Bear on Adhesion Prevention: Postsurgica...
    Robert A. Hammer, Abraham N. Morse, Jeffrey L. Cornella, Rebecca S. Keller, Joseph Hentz, John A. McDonald, Joseph C. Loftus
    Journal of Gynecologic Surgery
    Journal of Gynecologic Surgery Objective: Seprafilm,® (Genzyme, Cambridge, MA) an absorbable adhesion barrier incorporating hyaluronic acid (HA), a high molecular mass ...
  • Validation of a Mouse Adhesion Reduction Model Using Seprafilm...
    Abraham N. Morse, Robert A. Hammer, Jeffrey L. Cornella, Joseph C. Loftus
    Journal of Gynecologic Surgery
    This model has been validated using a hyaluronan/carboxymethylcellulose (HA/CMC) barrier (Seprafilm®; Genzyme, Somerville, NJ) currently in clinical use. Methods: Adult, FVB mice ...
  • Laparoscopic Adhesiolysis and Placement of Seprafilm(tm): A New...
    Leena Khaitan, Stefan Scholz, William O. Richards
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    Many surgeons argue that operative treatment of these patients exacerbates symptoms because of the continued adhesion formation following each procedure. Seprafilm(tm) (Genzyme, ...
  • Recombinant Human Thyrotropin is Helpful in the Follow-Up and...
    Susanne Kohlfuerst, Isabelle Igerc, Peter Lind
    Thyroid
    obtained a TSH level of greater than 80 mU/L after two injections of rhTSH (Thyrogen, Genzyme Corp., Cambridge, MA) 0.9 mg intramuscularly 24 hours and 48 hours before the ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll